| Oral agents |
| Antimuscarinic (selective) |
| Darifenacin ER (Enablex): low dosage | 7.5 mg daily | $90 to $145 |
| Darifenacin ER: maximum dosage | 15 mg daily | $90 to $110 |
| Solifenacin (Vesicare): low dosage | 5 mg daily | $135 to $145 |
| Solifenacin: maximum dosage | 10 mg daily | $135 to $145 |
| Antimuscarinic (nonselective) |
| | Oxybutynin: low dosage | 5 mg daily | $10 to $12 |
| Oxybutynin: intermediate dosage | 10 mg daily | $15 to $20 |
| Oxybutynin: maximum dosage | 30 mg daily | $30 to $45 |
| Tolterodine (Detrol): low dosage | 2 mg daily | $25 to $40 |
| Tolterodine: maximum dosage | 4 mg daily | $40 to $70 |
| Beta-adrenergic |
| Mirabegron†: low dosage | 25 mg daily | $385 to $410 |
| Mirabegron†: maximum dosage | 50 mg daily | $385 to $410 |
| Selective serotonin reuptake inhibitor |
| | Duloxetine (Cymbalta)‡ | 40 mg twice daily | $140 to $190 |
| Intravesicular injection |
| Neuromuscular blocker |
| | OnabotulinumtoxinA (Botox)† | 100 units/1 mL every 6 months | $600 to $630 |
| Transdermal agents |
| Antimuscarinic (nonselective) |
| | Oxybutynin† | One patch twice weekly | $30 |
| Estrogen derivative |
| | Vaginal estrogen (estradiol [Estrace], estrogen [Premarin])‡ | 0.5 to 2 g twice weekly | $95 to $350 |
